Reydis Pharmaceuticals Private Limited
About Reydis Pharmaceuticals Private Limited
Data last updated:
Reydis Pharmaceuticals Private Limited is a private limited company based in Tijara, Rajasthan, India. It operates in the wood and of products of wood and cork segment of the wood and timber products sector. It was incorporated on 13 March 2023.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U20297RJ2023PTC086277.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepak Kumar Jain and Saurabh Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tijara, Rajasthan.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.93 Lakh. For the same year it recorded a net loss of ₹2.76 Lakh (net margin -27.8%) and EBITDA of -₹2.76 Lakh (EBITDA margin -27.8%).
Company details
Contact details
Reydis Pharmaceuticals Private Limited's registered office is in Tijara, Rajasthan.
- Registered AddressC/O Subani Plot No. 39, Kaharani Industrial Area Bhiwadi Alwar, Tijara, Rajasthan, India – 301019
- IndustryWood, Wood And Of Products Of Wood And Cork, Manufacturing, Straw And Plaiting Materials, Products Of Wood, Cork
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reydis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Reydis Pharmaceuticals Private Limited
FY 2025 filings availableReydis Pharmaceuticals Private Limited reported revenue of ₹9.93 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.76 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.76 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -27.8% | ||
| Net Profit Margin | -27.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Reydis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Reydis Pharmaceuticals Private Limited
Reydis Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar Jain | Director | 13 Mar 2023 | 3 Years 7 Months | Current |
| Saurabh Sharma | Director | 16 Dec 2025 | 0 Years 10 Months | Current |
Peer comparison
Reydis Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Catkin Pharmaceuticals Private Limited | ₹9.96 Lakh (FY 2025) | -16.0% | Dehradun, Uttarakhand, India | |||
| Reydis Pharmaceuticals Private Limitedthis company | ₹9.93 Lakh (FY 2025) | -₹2.76 Lakh | -27.8% | Tijara, Rajasthan, India | ||
| Columbine Pharmaceuticals Private Limited | ₹9.9 Lakh (FY 2024) | 277.0% | Burdwan, West Bengal, India | |||
| Psynerva Pharmaceuticals Private Limited | ₹9.88 Lakh (FY 2024) | 52.0% | Patna, Bihar, India |
To see the full peer comparison of Reydis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reydis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reydis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Reydis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Reydis Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Saurabh Sharma was appointed as Director on 16 Dec 2025.
Frequently asked questions
Reydis Pharmaceuticals is an active private limited company based in Tijara, Rajasthan, India. The company works in wood and of products of wood and cork, within the wood industry. It was incorporated on 13 March 2023 (3+ years old) and is registered under CIN U20297RJ2023PTC086277.
Reydis Pharmaceuticals has 2 current directors:
- Deepak Kumar Jain - Director
- Saurabh Sharma - Director
The latest financial statements of Reydis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Reydis Pharmaceuticals is U20297RJ2023PTC086277. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reydis Pharmaceuticals was incorporated on 13 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Reydis Pharmaceuticals by revenue are Catkin Pharmaceuticals Private Limited, Columbine Pharmaceuticals Private Limited, Psynerva Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Saurabh Sharma was appointed as Director on 16 Dec 2025. Deepak Kumar Jain was appointed as Director on 13 Mar 2023. Raj Kumar Jain was appointed as Director on 13 Mar 2023.
The registered office of Reydis Pharmaceuticals is at CO Subani Plot No. 39, Kaharani Industrial Area Bhiwadi Alwar, Tijara, Rajasthan, India – 301019.
Reydis Pharmaceuticals operates in the wood industry, in the wood and of products of wood and cork segment.
Reydis Pharmaceuticals can be reached at its registered office: CO Subani Plot No. 39, Kaharani Industrial Area Bhiwadi Alwar, Tijara, Rajasthan, India – 301019.
Reydis Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Jaipur.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
